Fletcher Biosciences is developing a new generation of precision biologics designed to selectively target disease-driving immune cells.

Current immunotherapies often lack the ability to precisely target the immune cells driving disease, forcing reliance on broad immune suppression or modulation that can disrupt healthy immune function.

Fletcher is building a platform to design biologic therapies that precisely engage defined immune cell populations, enabling targeted approaches to correcting immune dysfunction across autoimmune disease, oncology, and infectious disease.

Fletcher Biosciences

Org chart

Teams

Offices